UCB Canada Inc. respectfully disagrees with the draft recommendation issued by the Canadian Drug Agency (CDA-AMC) regarding PrBIMZELX® (bimekizumab injection) for the treatment of adults living with ...
Based on the literature synthesis and system mapping presented in Section 2.4, a set of design requirements (DRs) was derived ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback